ENDOXAN I.V.

DRUG2 trials

Sponsors

Princess Maxima Center For Pediatric Oncology, Vall D Hebron Institute Of Oncology

Conditions

Acute lymphoblastic leukemiaAdvanced selected solid tumors: melanomanon-small cell lung cancer (NSCLC) and cervical cancer.

Phase 2

Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL

RecruitingCTIS2023-506400-99-00

Vall D Hebron Institute Of OncologyAdvanced selected solid tumors: melanoma, non-small cell lung cancer (NSCLC) and cervical cancer.

Start: 2025-01-15Target: 24Updated: 2025-12-02

Phase 3

Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia

SuspendedCTIS2022-502503-30-00

Princess Maxima Center For Pediatric OncologyAcute lymphoblastic leukemia

Start: 2022-12-15Target: 206Updated: 2026-01-27